Durvalumab vs Pantoprazole

Durvalumab vs Pantoprazole: Overview

This comparison examines the pharmacological differences between Durvalumab and Pantoprazole.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pantoprazole: Proton pump inhibitor.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Pantoprazole — 1 hour.

Chemical Properties

Molecular Formula: Pantoprazole — C16H15F2N3O4S.

Molecular Weight: Pantoprazole — 383.3710 g/mol.

Type: Durvalumab — Antibody; Pantoprazole — Small molecule.